openPR Logo
Press release

Osteoporosis Drugs Market Size - Forecasts to 2026

Osteoporosis Drugs Market

Osteoporosis Drugs Market

As per the research conducted by GME, the Osteoporosis Drugs Market will grow with a CAGR value of 3.7 percent by 2026. The increase in the incidence of osteoporosis is a significant trigger contributing to the advancement of the osteoporosis drug market. Other factors behind the expansion of the osteoporosis drugs market include an increase in the global elderly demographics and a rise in the acceptance of sedentary lifestyles.

Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Osteoporosis Drugs Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-osteoporosis-drugs-market-3154

By Product (Branded [Bisphosphonates, Parathyroid Hormone Therapy, Calcitonin, Selective Estrogen Inhibitors Modulator (SERM), Rank Ligand Inhibitors, and Others] and Generics), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), By Region (North America, Asia Pacific, CSA, Europe, and The Middle East and Africa); End-User, Landscape, Company Market Share Analysis, and Competitor Analysis
Key Market Insights
• Through the forecast period, emerging economies with strong growth prospects are supposed to provide attractive opportunities.
• Branded medicines are likely to be the highest-selling products because of increased spending by key players in the research & development activities of innovative novel drugs.
• Parenteral route of administration is foreseen to hold its predominance due to higher bioavailability and a faster mechanism of action.
• Hospital pharmacy is presumed to lead because of the surge in the proportion of patients attending hospitals for osteoporosis care.
• North America is foreseen to lead this market because the government has also been organizing awareness.
• Amgen Inc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Merck & Co. Inc., Novo Nordisk A/S, Novartis AG, Pfizer, Radius Health Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Ltd., and Teva Pharmaceutical Industries Ltd. among others, are the top players in the osteoporosis drugs market.

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-osteoporosis-drugs-market-3154

Product Outlook (Revenue, USD Billion, 2021-2026)
• Branded
• Bisphosphonates
• Parathyroid Hormone Therapy
• Calcitonin
• Selective Estrogen Inhibitors Modulator (SERM)
• Rank Ligand Inhibitors
• Others
• Generics

Route of Administration Outlook (Revenue, USD Billion, 2021-2026)
• Oral
• Parenteral

Distribution Channel Outlook (Revenue, USD Billion, 2021-2026)
• Hospital Pharmacies
• Retail Pharmacies
• Others

Regional Outlook (Revenue, USD Billion, 2021-2026)
North America
• The U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• UAE
• Rest of MEA

Contact: Yash Jain
Email address: yash.jain@globalmarketestimates.com
Phone Number: +16026667238
Website: https://www.globalmarketestimates.com/
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php

B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India

Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Osteoporosis Drugs Market Size - Forecasts to 2026 here

News-ID: 2287474 • Views:

More Releases from Global Market Estimates Research & Consultants

Global Market Estimates Hosts Exclusive Webinar on Future Trends in Quick Commerce
Global Market Estimates Hosts Exclusive Webinar on Future Trends in Quick Commer …
Gain Strategic Insights and a Comprehensive Report on August 1st Global Market Estimates (GME) is excited to announce an exclusive webinar, "Future Trends in the Global Quick Commerce Market: Forecasts to 2029," scheduled for August 1, 2024, at 11am EST. This insightful session will feature Mr. Yash Jain, Director - Global Accounts & Strategic Advisory. For a registration fee of USD 499, attendees will receive a comprehensive report valued at USD 5,450,
Global Flare Monitoring Market Size & Trends
Global Flare Monitoring Market Size & Trends
According to a new market research report published by Global Market Estimates, the global flare monitoring market is expected to grow at a CAGR of 6.5% from 2024 to 2029. Global flare monitoring market growth is driven by factors such as safety and risk management and growing emphasis on reduction of emissions. Unlock the Executive Summary of the report at only USD 249. Book a call now: https://tidycal.com/yashsushiljain/unlock-strategic-insights-press-release Key Market Insights • As per
Global Fiber Optic Component System Market Size & Trends
Global Fiber Optic Component System Market Size & Trends
According to a new market research report published by Global Market Estimates, the global fiber optic component system market is expected to grow at a CAGR of 8.46 % from 2024 to 2029. Global fiber optic component system market growth is driven by factors such as growing demand for safety regulations and technological developments. Unlock the Executive Summary of the report at only USD 249. Book a call now: https://tidycal.com/yashsushiljain/unlock-strategic-insights-press-release Key Market
Global Rechargeable Battery Market Size & Trends
Global Rechargeable Battery Market Size & Trends
According to a new market research report published by Global Market Estimates, the global rechargeable battery market is expected to grow at a CAGR of 15.4% from 2024 to 2029. Rechargeable batteries have been growing in popularity due to their inherent superiority over disposable batteries in environmental pollution. As rechargeable batteries can be recharged after every use, they cause much lower environmental degradation as compared to disposable batteries, which are discarded

All 5 Releases


More Releases for Osteoporosis

Rising Prevalence Of Osteoporosis Fuels Growth In Osteoporosis Treatment Market: …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Osteoporosis Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In the realm of osteoporosis treatments, the market has seen consistent expansion recently, projected to increase its valuation from $13.96 billion in 2024 to $14.57 billion come 2025, reflecting a compound annual growth rate of
Rising Prevalence Of Osteoporosis Spurs Momentum In Postmenopausal Osteoporosis …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Postmenopausal Osteoporosis Treatment Market Through 2025? Valuations for the marketplace addressing postmenopausal osteoporosis treatments have demonstrated consistent upward movement throughout the preceding years, projecting an expansion from a figure of $10.1 billion in 2024 to an anticipated $10.54 billion by 2025, reflecting
Rising Prevalence Of Osteoporosis Fuels Growth In The Osteoporosis Drug Market: …
The Osteoporosis Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Osteoporosis Drugs Market Size During the Forecast Period? The market for medications for osteoporosis has seen a consistent rise in recent years. The current market value of $12.33 billion in 2024
Rising Prevalence Of Osteoporosis Spurs Momentum In Postmenopausal Osteoporosis …
The Postmenopausal Osteoporosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Postmenopausal Osteoporosis Treatment Market Size and Its Estimated Growth Rate? The market for treatment of postmenopausal osteoporosis has seen a steady increase in size over the recent years. It's projected
Osteoporosis Drug Market, By Type (Primary Osteoporosis and Secondary Osteoporos …
Osteoporosis is a condition of bone weakening or bones becomes fragile and likely to break. In other words, osteoporosis is a condition wherein the bone density decreases. This is specially witnessed in old age people. Osteoporosis brings along back pain, stooped posture, bone fracture and tooth loss. View Detailed Report" https://www.databridgemarketresearch.com/reports/global-osteoporosis-drug-market The global osteoporosis drug market is experiencing steady growth driven by factors such as the increasing aging population, rising prevalence of
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.